No interest in PRPH($5.45), jtomm. While you view the CEO as "generally optimistic", I view him as too promotional and not very trustworthy. The stock could obviously work if they really gained traction in the genomics sector, but the progress there so far is not inspiring.
We make a living by what we get, we make a life by what we give. --Winston Churchill
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.